ORAL ONCOL 润色咨询

ORAL ONCOLOGY

出版年份:1997 年文章数:2884 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:8.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗?这个好像没有影响因子<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:杂志很好,头颈的基础的文章很难命中,仅仅5-7个实验满足不了基础方向编辑的胃口,临床方向结合基础,比较适合命中。文章的结果及讨论要求高,小修的意见中,提到数据问题,必须老实回答。对中国的研究数据稍微有点小疑问,但如实回答后,直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:基础研究;头颈肿瘤<br>经验分享:刚中一篇,口腔癌基础研究,还挺开心的。<br>2020.3.2投稿,2020.5.26返回审稿意见,两个审稿人意见都比较正面;第一个提了两个问题,第二个提了9个问题,一一回答。2020.7.2返回Revision,2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:之前投放疗绿皮被拒,改天这个杂志,7-6号投稿,7-7 with editor,7-13 under review,送了2+个审稿人,其中两个审稿人接受审稿,7-17第一个审稿人完成审稿,7-25第二个审稿人完成审稿,目前是required reviews completed状态,希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:小白,来弱弱问一下,让转投成letter,不知道letter怎么样,值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了,绿皮外审后给了一些意见,按照给的意见一一修正后,改投oral oncology,2023.09.12投稿,09.13 状态with editor 09.18还是with editor,改了一个时间,期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:口腔肿瘤<br>经验分享:已经with editor一个月了 还没有回复 催了一次,不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:OO官网自我介绍的录用率为22%,没有这里介绍的高。还有一个问题,我发现每一期article和letter的比例至少是1:1.5,甚至接近1:2,如果22%包括letter,那么article的录用率不到10%,有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多,估算下来一年中国发表40-50篇文章,自然是包括letter的,似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2023-09-20 ms7000000929368825 来自广东省

    请问有收到让转投oral oncology reports的吗?这个好像没有影响因子

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗?这个好像没有影响因子<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:杂志很好,头颈的基础的文章很难命中,仅仅5-7个实验满足不了基础方向编辑的胃口,临床方向结合基础,比较适合命中。文章的结果及讨论要求高,小修的意见中,提到数据问题,必须老实回答。对中国的研究数据稍微有点小疑问,但如实回答后,直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:基础研究;头颈肿瘤<br>经验分享:刚中一篇,口腔癌基础研究,还挺开心的。<br>2020.3.2投稿,2020.5.26返回审稿意见,两个审稿人意见都比较正面;第一个提了两个问题,第二个提了9个问题,一一回答。2020.7.2返回Revision,2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:之前投放疗绿皮被拒,改天这个杂志,7-6号投稿,7-7 with editor,7-13 under review,送了2+个审稿人,其中两个审稿人接受审稿,7-17第一个审稿人完成审稿,7-25第二个审稿人完成审稿,目前是required reviews completed状态,希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:小白,来弱弱问一下,让转投成letter,不知道letter怎么样,值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了,绿皮外审后给了一些意见,按照给的意见一一修正后,改投oral oncology,2023.09.12投稿,09.13 状态with editor 09.18还是with editor,改了一个时间,期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:口腔肿瘤<br>经验分享:已经with editor一个月了 还没有回复 催了一次,不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:OO官网自我介绍的录用率为22%,没有这里介绍的高。还有一个问题,我发现每一期article和letter的比例至少是1:1.5,甚至接近1:2,如果22%包括letter,那么article的录用率不到10%,有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多,估算下来一年中国发表40-50篇文章,自然是包括letter的,似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2012-07-05 匿名用户

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享:杂志很好,头颈的基础的文章很难命中,仅仅5-7个实验满足不了基础方向编辑的胃口,临床方向结合基础,比较适合命中。文章的结果及讨论要求高,小修的意见中,提到数据问题,必须老实回答。对中国的研究数据稍微有点小疑问,但如实回答后,直接接收。

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗?这个好像没有影响因子<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:杂志很好,头颈的基础的文章很难命中,仅仅5-7个实验满足不了基础方向编辑的胃口,临床方向结合基础,比较适合命中。文章的结果及讨论要求高,小修的意见中,提到数据问题,必须老实回答。对中国的研究数据稍微有点小疑问,但如实回答后,直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:基础研究;头颈肿瘤<br>经验分享:刚中一篇,口腔癌基础研究,还挺开心的。<br>2020.3.2投稿,2020.5.26返回审稿意见,两个审稿人意见都比较正面;第一个提了两个问题,第二个提了9个问题,一一回答。2020.7.2返回Revision,2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:之前投放疗绿皮被拒,改天这个杂志,7-6号投稿,7-7 with editor,7-13 under review,送了2+个审稿人,其中两个审稿人接受审稿,7-17第一个审稿人完成审稿,7-25第二个审稿人完成审稿,目前是required reviews completed状态,希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:小白,来弱弱问一下,让转投成letter,不知道letter怎么样,值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了,绿皮外审后给了一些意见,按照给的意见一一修正后,改投oral oncology,2023.09.12投稿,09.13 状态with editor 09.18还是with editor,改了一个时间,期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:口腔肿瘤<br>经验分享:已经with editor一个月了 还没有回复 催了一次,不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:OO官网自我介绍的录用率为22%,没有这里介绍的高。还有一个问题,我发现每一期article和letter的比例至少是1:1.5,甚至接近1:2,如果22%包括letter,那么article的录用率不到10%,有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多,估算下来一年中国发表40-50篇文章,自然是包括letter的,似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2020-08-01 paw2020

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:基础研究;头颈肿瘤
    经验分享:刚中一篇,口腔癌基础研究,还挺开心的。
    2020.3.2投稿,2020.5.26返回审稿意见,两个审稿人意见都比较正面;第一个提了两个问题,第二个提了9个问题,一一回答。2020.7.2返回Revision,2020.7.28接受。

    9

    展开9条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗?这个好像没有影响因子<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:杂志很好,头颈的基础的文章很难命中,仅仅5-7个实验满足不了基础方向编辑的胃口,临床方向结合基础,比较适合命中。文章的结果及讨论要求高,小修的意见中,提到数据问题,必须老实回答。对中国的研究数据稍微有点小疑问,但如实回答后,直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:基础研究;头颈肿瘤<br>经验分享:刚中一篇,口腔癌基础研究,还挺开心的。<br>2020.3.2投稿,2020.5.26返回审稿意见,两个审稿人意见都比较正面;第一个提了两个问题,第二个提了9个问题,一一回答。2020.7.2返回Revision,2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:之前投放疗绿皮被拒,改天这个杂志,7-6号投稿,7-7 with editor,7-13 under review,送了2+个审稿人,其中两个审稿人接受审稿,7-17第一个审稿人完成审稿,7-25第二个审稿人完成审稿,目前是required reviews completed状态,希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:小白,来弱弱问一下,让转投成letter,不知道letter怎么样,值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了,绿皮外审后给了一些意见,按照给的意见一一修正后,改投oral oncology,2023.09.12投稿,09.13 状态with editor 09.18还是with editor,改了一个时间,期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:口腔肿瘤<br>经验分享:已经with editor一个月了 还没有回复 催了一次,不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:OO官网自我介绍的录用率为22%,没有这里介绍的高。还有一个问题,我发现每一期article和letter的比例至少是1:1.5,甚至接近1:2,如果22%包括letter,那么article的录用率不到10%,有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多,估算下来一年中国发表40-50篇文章,自然是包括letter的,似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2023-07-26 夜夜笙歌 来自广西

    偏重的研究方向:头颈肿瘤;肿瘤
    经验分享:之前投放疗绿皮被拒,改天这个杂志,7-6号投稿,7-7 with editor,7-13 under review,送了2+个审稿人,其中两个审稿人接受审稿,7-17第一个审稿人完成审稿,7-25第二个审稿人完成审稿,目前是required reviews completed状态,希望有个好结果

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗?这个好像没有影响因子<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:杂志很好,头颈的基础的文章很难命中,仅仅5-7个实验满足不了基础方向编辑的胃口,临床方向结合基础,比较适合命中。文章的结果及讨论要求高,小修的意见中,提到数据问题,必须老实回答。对中国的研究数据稍微有点小疑问,但如实回答后,直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:基础研究;头颈肿瘤<br>经验分享:刚中一篇,口腔癌基础研究,还挺开心的。<br>2020.3.2投稿,2020.5.26返回审稿意见,两个审稿人意见都比较正面;第一个提了两个问题,第二个提了9个问题,一一回答。2020.7.2返回Revision,2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:之前投放疗绿皮被拒,改天这个杂志,7-6号投稿,7-7 with editor,7-13 under review,送了2+个审稿人,其中两个审稿人接受审稿,7-17第一个审稿人完成审稿,7-25第二个审稿人完成审稿,目前是required reviews completed状态,希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:小白,来弱弱问一下,让转投成letter,不知道letter怎么样,值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了,绿皮外审后给了一些意见,按照给的意见一一修正后,改投oral oncology,2023.09.12投稿,09.13 状态with editor 09.18还是with editor,改了一个时间,期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:口腔肿瘤<br>经验分享:已经with editor一个月了 还没有回复 催了一次,不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:OO官网自我介绍的录用率为22%,没有这里介绍的高。还有一个问题,我发现每一期article和letter的比例至少是1:1.5,甚至接近1:2,如果22%包括letter,那么article的录用率不到10%,有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多,估算下来一年中国发表40-50篇文章,自然是包括letter的,似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2023-10-10 零羚翎 来自辽宁省

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:小白,来弱弱问一下,让转投成letter,不知道letter怎么样,值不值得投

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗?这个好像没有影响因子<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:杂志很好,头颈的基础的文章很难命中,仅仅5-7个实验满足不了基础方向编辑的胃口,临床方向结合基础,比较适合命中。文章的结果及讨论要求高,小修的意见中,提到数据问题,必须老实回答。对中国的研究数据稍微有点小疑问,但如实回答后,直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:基础研究;头颈肿瘤<br>经验分享:刚中一篇,口腔癌基础研究,还挺开心的。<br>2020.3.2投稿,2020.5.26返回审稿意见,两个审稿人意见都比较正面;第一个提了两个问题,第二个提了9个问题,一一回答。2020.7.2返回Revision,2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:之前投放疗绿皮被拒,改天这个杂志,7-6号投稿,7-7 with editor,7-13 under review,送了2+个审稿人,其中两个审稿人接受审稿,7-17第一个审稿人完成审稿,7-25第二个审稿人完成审稿,目前是required reviews completed状态,希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:小白,来弱弱问一下,让转投成letter,不知道letter怎么样,值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了,绿皮外审后给了一些意见,按照给的意见一一修正后,改投oral oncology,2023.09.12投稿,09.13 状态with editor 09.18还是with editor,改了一个时间,期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:口腔肿瘤<br>经验分享:已经with editor一个月了 还没有回复 催了一次,不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:OO官网自我介绍的录用率为22%,没有这里介绍的高。还有一个问题,我发现每一期article和letter的比例至少是1:1.5,甚至接近1:2,如果22%包括letter,那么article的录用率不到10%,有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多,估算下来一年中国发表40-50篇文章,自然是包括letter的,似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2023-09-19 89413_0661 来自重庆

    之前投的放疗绿皮被拒了,绿皮外审后给了一些意见,按照给的意见一一修正后,改投oral oncology,2023.09.12投稿,09.13 状态with editor 09.18还是with editor,改了一个时间,期待好运。

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗?这个好像没有影响因子<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:杂志很好,头颈的基础的文章很难命中,仅仅5-7个实验满足不了基础方向编辑的胃口,临床方向结合基础,比较适合命中。文章的结果及讨论要求高,小修的意见中,提到数据问题,必须老实回答。对中国的研究数据稍微有点小疑问,但如实回答后,直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:基础研究;头颈肿瘤<br>经验分享:刚中一篇,口腔癌基础研究,还挺开心的。<br>2020.3.2投稿,2020.5.26返回审稿意见,两个审稿人意见都比较正面;第一个提了两个问题,第二个提了9个问题,一一回答。2020.7.2返回Revision,2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:之前投放疗绿皮被拒,改天这个杂志,7-6号投稿,7-7 with editor,7-13 under review,送了2+个审稿人,其中两个审稿人接受审稿,7-17第一个审稿人完成审稿,7-25第二个审稿人完成审稿,目前是required reviews completed状态,希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:小白,来弱弱问一下,让转投成letter,不知道letter怎么样,值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了,绿皮外审后给了一些意见,按照给的意见一一修正后,改投oral oncology,2023.09.12投稿,09.13 状态with editor 09.18还是with editor,改了一个时间,期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:口腔肿瘤<br>经验分享:已经with editor一个月了 还没有回复 催了一次,不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:OO官网自我介绍的录用率为22%,没有这里介绍的高。还有一个问题,我发现每一期article和letter的比例至少是1:1.5,甚至接近1:2,如果22%包括letter,那么article的录用率不到10%,有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多,估算下来一年中国发表40-50篇文章,自然是包括letter的,似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2022-10-11 ms2000002115367694

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:口腔肿瘤
    经验分享:已经with editor一个月了 还没有回复 催了一次,不知道要多久啊

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗?这个好像没有影响因子<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:杂志很好,头颈的基础的文章很难命中,仅仅5-7个实验满足不了基础方向编辑的胃口,临床方向结合基础,比较适合命中。文章的结果及讨论要求高,小修的意见中,提到数据问题,必须老实回答。对中国的研究数据稍微有点小疑问,但如实回答后,直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:基础研究;头颈肿瘤<br>经验分享:刚中一篇,口腔癌基础研究,还挺开心的。<br>2020.3.2投稿,2020.5.26返回审稿意见,两个审稿人意见都比较正面;第一个提了两个问题,第二个提了9个问题,一一回答。2020.7.2返回Revision,2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:之前投放疗绿皮被拒,改天这个杂志,7-6号投稿,7-7 with editor,7-13 under review,送了2+个审稿人,其中两个审稿人接受审稿,7-17第一个审稿人完成审稿,7-25第二个审稿人完成审稿,目前是required reviews completed状态,希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:小白,来弱弱问一下,让转投成letter,不知道letter怎么样,值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了,绿皮外审后给了一些意见,按照给的意见一一修正后,改投oral oncology,2023.09.12投稿,09.13 状态with editor 09.18还是with editor,改了一个时间,期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:口腔肿瘤<br>经验分享:已经with editor一个月了 还没有回复 催了一次,不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:OO官网自我介绍的录用率为22%,没有这里介绍的高。还有一个问题,我发现每一期article和letter的比例至少是1:1.5,甚至接近1:2,如果22%包括letter,那么article的录用率不到10%,有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多,估算下来一年中国发表40-50篇文章,自然是包括letter的,似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2022-10-29 alanhuang

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:OO官网自我介绍的录用率为22%,没有这里介绍的高。还有一个问题,我发现每一期article和letter的比例至少是1:1.5,甚至接近1:2,如果22%包括letter,那么article的录用率不到10%,有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多,估算下来一年中国发表40-50篇文章,自然是包括letter的,似乎也没想象中那么难。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗?这个好像没有影响因子<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:杂志很好,头颈的基础的文章很难命中,仅仅5-7个实验满足不了基础方向编辑的胃口,临床方向结合基础,比较适合命中。文章的结果及讨论要求高,小修的意见中,提到数据问题,必须老实回答。对中国的研究数据稍微有点小疑问,但如实回答后,直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:基础研究;头颈肿瘤<br>经验分享:刚中一篇,口腔癌基础研究,还挺开心的。<br>2020.3.2投稿,2020.5.26返回审稿意见,两个审稿人意见都比较正面;第一个提了两个问题,第二个提了9个问题,一一回答。2020.7.2返回Revision,2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:之前投放疗绿皮被拒,改天这个杂志,7-6号投稿,7-7 with editor,7-13 under review,送了2+个审稿人,其中两个审稿人接受审稿,7-17第一个审稿人完成审稿,7-25第二个审稿人完成审稿,目前是required reviews completed状态,希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:小白,来弱弱问一下,让转投成letter,不知道letter怎么样,值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了,绿皮外审后给了一些意见,按照给的意见一一修正后,改投oral oncology,2023.09.12投稿,09.13 状态with editor 09.18还是with editor,改了一个时间,期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:口腔肿瘤<br>经验分享:已经with editor一个月了 还没有回复 催了一次,不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:OO官网自我介绍的录用率为22%,没有这里介绍的高。还有一个问题,我发现每一期article和letter的比例至少是1:1.5,甚至接近1:2,如果22%包括letter,那么article的录用率不到10%,有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多,估算下来一年中国发表40-50篇文章,自然是包括letter的,似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2022-03-24 1465389cm38暂无昵称

    偏重的研究方向:头颈肿瘤;肿瘤
    经验分享:Mar 23 required review completed

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗?这个好像没有影响因子<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:杂志很好,头颈的基础的文章很难命中,仅仅5-7个实验满足不了基础方向编辑的胃口,临床方向结合基础,比较适合命中。文章的结果及讨论要求高,小修的意见中,提到数据问题,必须老实回答。对中国的研究数据稍微有点小疑问,但如实回答后,直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:基础研究;头颈肿瘤<br>经验分享:刚中一篇,口腔癌基础研究,还挺开心的。<br>2020.3.2投稿,2020.5.26返回审稿意见,两个审稿人意见都比较正面;第一个提了两个问题,第二个提了9个问题,一一回答。2020.7.2返回Revision,2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:之前投放疗绿皮被拒,改天这个杂志,7-6号投稿,7-7 with editor,7-13 under review,送了2+个审稿人,其中两个审稿人接受审稿,7-17第一个审稿人完成审稿,7-25第二个审稿人完成审稿,目前是required reviews completed状态,希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:小白,来弱弱问一下,让转投成letter,不知道letter怎么样,值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了,绿皮外审后给了一些意见,按照给的意见一一修正后,改投oral oncology,2023.09.12投稿,09.13 状态with editor 09.18还是with editor,改了一个时间,期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:口腔肿瘤<br>经验分享:已经with editor一个月了 还没有回复 催了一次,不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:OO官网自我介绍的录用率为22%,没有这里介绍的高。还有一个问题,我发现每一期article和letter的比例至少是1:1.5,甚至接近1:2,如果22%包括letter,那么article的录用率不到10%,有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多,估算下来一年中国发表40-50篇文章,自然是包括letter的,似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向:头颈肿瘤;肿瘤<br>经验分享:Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2022-05-27 1465389cm38暂无昵称

    May 24th Accept

    0

共96条页码: 1/10页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分